Genetic Signatures Limited

ASX (AUD): Genetic Signatures Limited (GSS)

Last Price

0.44

Today's Change

+0.04 (10.00%)

Day's Change

0.41 - 0.44

Trading Volume

88,203

Overview

Market Cap

99 Million

Shares Outstanding

227 Million

Avg Volume

111,436

Avg Price (50 Days)

0.50

Avg Price (200 Days)

0.63

PE Ratio

-4.40

EPS

-0.10

Earnings Announcement

28-Aug-2025

Previous Close

0.40

Open

0.41

Day's Range

0.41 - 0.44

Year Range

0.36 - 0.85

Trading Volume

74,965

Price Change Highlight

1 Day Change

10.00%

5 Day Change

0.00%

1 Month Change

-16.19%

3 Month Change

-29.03%

6 Month Change

-27.27%

Ytd Change

-33.33%

1 Year Change

-35.77%

3 Year Change

-66.67%

5 Year Change

-75.00%

10 Year Change

14.04%

Max Change

-7.12%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment